ACP5
protein-codingacid phosphatase 5, tartrate resistant, the group of Acid phosphatases
Gene summary
This gene encodes an iron containing glycoprotein which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. [provided by RefSeq, Aug 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011939
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011939
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011939
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011939
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Endocrine; Musculoskeletal; Neurologic
Intervention: Allergy/Immunology/Infectious
Rationale: Individuals may have immune deficiency, and a variety of infections have been reported, including pneunomia, upper respiratory infections, and severe varicella infections, and thus antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Individuals may also have a variety of autoimmune manifestations, including hypothyroidism, and treatment may be beneficial
Comments: Clinically recognizable non-immune features may not be recognized early; The condition can affect multiple organ systems for which early knowledge of disease could be beneficial, including infectious and autoimmune sequelae
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACP5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001611.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 89 | 2 | 91 | |||
| missense | 4 | 6 | 152 | 12 | 1 | 175 |
| nonsense | 6 | 4 | 3 | 13 | ||
| start loss | 1 | 1 | ||||
| frameshift | 17 | 5 | 1 | 23 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 28 | 15 | 158 | 101 | 3 | 305 |
Highest pathogenic variant AF is 0.000042745367
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001602.1 | 4 | MANE Select | |
| Ensembl | ENSP00000496973.1 | 4 | MANE Select | |
| RefSeq | NP_001104504.1 | 4 | Standard | |
| RefSeq | NP_001104505.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysosome - Homo sapiens (human)
- Riboflavin metabolism - Homo sapiens (human)
- Rheumatoid arthritis - Homo sapiens (human)
- Osteoclast differentiation - Homo sapiens (human)
- Osteoclast Signaling
Biological Process
- ossification
- riboflavin metabolic process
- dephosphorylation
- response to lipopolysaccharide
- negative regulation of interleukin-1 beta production
Molecular Function
- acid phosphatase activity
- ferrous iron binding
- ferric iron binding
Cellular Component
- lysosome
- cytosol
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000592828
- Coding exons
- 4
- Length
- 4349
- Individuals with no LoFs
- 125733
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 15
- Defined
- 125748
- p
- 0.0000596
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.400 | 181 | 197 | 0.920 | 0.0000128 | 2096 |
| Missense (PolyPhen) | 50 | 78.818 | 0.63437 | 894 | ||
| Synonymous | 0.560 | 80 | 86.6 | 0.924 | 0.00000580 | 687 |
| Loss of Function | 2.25 | 4 | 12.6 | 0.317 | 6.33e-7 | 121 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias.;
- Disease
- DISEASE: Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]: A disease characterized by vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases. The skeletal dysplasia is characterized by radiolucent and irregular spondylar and metaphyseal lesions that represent islands of chondroid tissue within bone. {ECO:0000269|PubMed:21217752, ECO:0000269|PubMed:21217755}. Note=The disease is caused by mutations affecting the gene represented in this entry. ACP5 inactivating mutations result in a functional excess of phosphorylated osteopontin causing deregulation of osteopontin signaling and consequential autoimmune disease.;
Recessive Scores
- pRec
- 0.254
Intolerance Scores
- LoFtool
- 0.138
- RVIS EVS
- 0.35
- RVIS percentile EVS
- 74.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.995
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |